In-Person Addiction Medicine for St. Charles County
St. Charles County patients cross the Missouri River for care that treats addiction as a medical condition rather than a moral failing, with a treatment plan built around work and family commitments.
Crossing the river is a deliberate choice, and the patients who make it are usually looking for a clinic that treats addiction as a medical condition with a plan built around work and family. The visit schedule is designed to be kept, not merely prescribed.
East on I-70 across the Blanchette Bridge, exiting near the airport for Woodson Rd. The clinic is at 4477 Woodson Rd, Suite 101, St. Louis, MO 63134, next to St. Louis Lambert International Airport.
Programs for St. Charles County patients
Each delivered in person at the Woodson Rd clinic:
Opioid Addiction Treatment
Buprenorphine/naloxone, with the visit interval built around the drive. What this involves.
Alcohol Addiction Treatment
Alcohol use disorder, medically managed and reviewed. What this involves.
Drug Addiction Treatment
Drug and polysubstance use, alongside the co-occurring conditions. What this involves.
What stable actually means
Stability in addiction medicine is not the absence of any difficulty. It is a specific and observable set of things: the medication dose is holding across the whole day, cravings are manageable rather than governing the schedule, screening is consistent with the plan, and the parts of life that were falling away — work, housing, relationships — are being rebuilt rather than lost.
It matters because it is the point at which the treatment changes shape. Frequent visits are a feature of the opening phase, not a permanent condition, and the interval lengthens substantially once someone is stable.
For patients crossing the river that change is worth naming at the start, because the schedule people imagine when they hear office-based treatment is usually the intensive early version rather than what most of the year looks like.
Why a taper is a decision and not a graduation
Patients regularly ask how long they will be on medication, and behind the question is usually an assumption that stopping is the goal and staying on is a failure to finish. That framing does real harm.
The evidence is uncomfortable for it. Discontinuing buprenorphine is associated with a substantial rise in return to use and in overdose risk, and the risk is highest in the period immediately after stopping, when tolerance has fallen. A taper undertaken because a calendar said so, rather than because a patient’s life is ready for it, is a clinical decision with a body count.
So the position here is that tapering is available, it is planned rather than imposed, and it happens when your circumstances support it. Nobody is discharged for still needing treatment.
Screening and the visit schedule are calibrated, not fixed
The frequency of visits and screening in the opening phase is high because that is where the clinical work is: adjusting the dose, catching the additions that change risk, and being reachable while things are still moving.
As stability is established, both step down. That is not a reward for good behavior, it is a change in what is clinically necessary, and it is worth understanding in those terms rather than as a system of privileges.
What does not change is that a result showing continued use is treated as information about the plan. It prompts a conversation about what is not working, not a discharge. Practices that remove people for positive screens produce worse outcomes, and keeping people in treatment is the whole point.
The things that undo stability are rarely the drug
Once medication is settled, the events that most often precipitate a return to use are not cravings appearing out of nowhere. They are sleep collapsing, untreated pain flaring, a psychiatric condition going unaddressed, a relationship ending, or a job lost.
That is why those things are treated as part of addiction care here rather than as somebody else’s department. Untreated pain in particular is a common route back, and it is the reason this practice combines interventional pain medicine with addiction medicine rather than referring between the two.
Pain and addiction are related covers how they are handled together, and pain management rehabilitation covers the functional side.
Making a longer drive workable
St. Charles patients cross the river for this, and the schedule is built with that in mind. Appointments are timed to avoid the worst of the bridge, follow-up that does not require an examination is handled by phone, and the visit interval stretches as soon as it clinically can.
What is not negotiable is that the medical visit itself happens in person. Evaluation, examination and prescribing are done in the room, every time. Phone contact exists for urgent support between visits, because patients in this population destabilize and need reaching — it monitors, it never prescribes.
That distinction is the reason a clinic-based practice can be safe for people who are genuinely unwell, and it is worth being precise about rather than blurring.
What St. Charles patients ask
Is it worth crossing the river for treatment?
That is a personal call, but the trip is a straight run on I-70 and the schedule is built to keep the number of trips low while staying entirely in person.
Can I taper off the medication eventually?
Yes, and it is planned with you rather than imposed on you. What we will not do is push a taper on a schedule your circumstances do not support, because stopping is the point at which overdose risk rises most sharply.
Do I have to drive over for every follow-up?
No. Follow-up that genuinely needs an examination happens here; the rest can be handled by phone. The medical visit where prescribing occurs is always in person.
Across the Blanchette Bridge
Addictionology Center
4477 Woodson Rd, Suite 101
St. Louis, MO 63134
Next to St. Louis Lambert International Airport.
Phone: +1 (314) 463-0100
Hours: Monday–Friday, 8:00 AM – 5:00 PM